Currently, although it is possible to produce eukaryotic proteins in prokaryotic expression systems, the recombinant proteins generated often exhibit adverse characteristics that may impact their efficacy, such as lacking glycosylation. Mammalian cell expression systems offer unique advantages by providing a transcription and translation environment close to the wild-type, coupled with relevant chaperones, secretion, oxidative-reductive conditions and post-translational modifications that contribute to the functionality and activity of the expressed proteins.

(Hunter M, et al. Curr Protoc Protein Sci. 2019)
We have decades of experience and expertise in transient and stable expression in eukaryotic mammalian cells. We have developed a proprietary set of vectors tailored for preferred host cell types (HEK293 cells and CHO cells), along with optimized serum-free culture systems. Through improved expression and purification strategies, we aim to further enhance the yield and cost-effectiveness of recombinant proteins.